# Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration

> **NCT01601483** · PHASE2,PHASE3 · TERMINATED · sponsor: **MacuCLEAR, Inc.** · enrollment: 22 (actual)

## Conditions studied

- Nonexudative Age Related Macular Degeneration

## Interventions

- **DRUG:** MC-1101
- **DRUG:** MC-1101 Vehicle

## Key facts

- **NCT ID:** NCT01601483
- **Lead sponsor:** MacuCLEAR, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Unmasked without Sponsor's prior knowledge or authorization by the PI.
- **Last updated:** 2014-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601483, "Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01601483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*